ROGAINE (FOR MEN) Drug Patent Profile
✉ Email this page to a colleague
When do Rogaine (for Men) patents expire, and what generic alternatives are available?
Rogaine (for Men) is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in ROGAINE (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rogaine (for Men)
A generic version of ROGAINE (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROGAINE (FOR MEN)?
- What are the global sales for ROGAINE (FOR MEN)?
- What is Average Wholesale Price for ROGAINE (FOR MEN)?
Summary for ROGAINE (FOR MEN)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 6 |
| DailyMed Link: | ROGAINE (FOR MEN) at DailyMed |
-patent-expirations.png "ROGAINE (FOR MEN) drug patent expirations")
Recent Clinical Trials for ROGAINE (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ohio State University Comprehensive Cancer Center | Early Phase 1 |
| Loyola University | Phase 2 |
| Cures Within Reach | Phase 2 |
Pharmacology for ROGAINE (FOR MEN)
| Drug Class | Arteriolar Vasodilator |
| Physiological Effect | Arteriolar Vasodilation |
US Patents and Regulatory Information for ROGAINE (FOR MEN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | ROGAINE (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 019501-002 | Feb 9, 1996 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
